Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2020-01-10 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
(1) PROPOSED INCREASE IN REGISTERED CAPITAL AND (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Capital/Financing Update Classification · 95% confidence The document is an announcement from Pharmaron Beijing Co., Ltd. regarding a proposed increase in registered capital and proposed amendments to the Articles of Association. It references shareholder meetings (EGM and H Shares Class Meeting) to approve these proposals. The content focuses on corporate governance changes related to share capital and articles of association amendments, not on financial results, audit, or other report types. It is not a full report but an announcement of corporate actions requiring shareholder approval. Therefore, it fits best under the category of Capital/Financing Update (CAP), as it deals with changes in the company's capital structure and related governance amendments.
2020-01-10 English
NOTICE OF THE FIRST H SHARES CLASS MEETING OF 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a notice for the first H Shares Class Meeting of 2020 for Pharmaron Beijing Co., Ltd. It details the meeting date, location, agenda (special resolution on increase of registered capital), voting procedures, proxy appointment instructions, and other logistical information. There is no financial data, management discussion, or report content. The document serves as an announcement to shareholders about the meeting and related voting rights, not the results or the report itself. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and voting rights rather than solicitation materials or proxy forms, it aligns best with DVA as it relates to voting rights announcements and meeting notices. Confidence is high due to clear meeting notice and voting instructions.
2020-01-10 English
NOTICE OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2020
AGM Information Classification · 95% confidence The document is a notice for the first Extraordinary General Meeting (EGM) of 2020 for Pharmaron Beijing Co., Ltd. It includes details about the meeting date, location, agenda items (special and ordinary resolutions), proxy appointment instructions, and shareholder registration information. There are no financial statements, management discussion, or detailed financial data presented. The document serves as an announcement to shareholders about the upcoming EGM and the matters to be voted on, rather than the results of the vote or the meeting itself. Therefore, it is best classified as a notice of a shareholder meeting, which fits the category of AGM Information (AGM-R), as it is a presentation/material shared for a general meeting (in this case, an extraordinary general meeting).
2020-01-10 English
Reply Slip for the First H Shares Class Meeting of 2020
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a reply slip for a shareholder meeting, specifically the First H Shares Class Meeting of 2020 for Pharmaron Beijing Co., Ltd. It is a form for shareholders to confirm attendance and voting intentions at the meeting. There is no financial data, report content, or detailed presentation included. The document is related to shareholder meeting logistics rather than the meeting materials or results. Therefore, it is best classified as a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2020-01-10 English
Reply Slip for the First Extraordinary General Meeting of 2020 (Applicable to H Shareholders)
Regulatory Filings Classification · 95% confidence The document is a reply slip for the First Extraordinary General Meeting (EGM) of 2020 of Pharmaron Beijing Co., Ltd. It is a form for shareholders to confirm attendance at the EGM, including instructions on how to submit the reply slip and deadlines. There is no financial data, report content, or detailed meeting materials included. The document is related to shareholder meeting logistics rather than the meeting materials or voting results. It is not an Annual Report, Interim Report, or any financial disclosure. It is also not a Proxy Solicitation or Voting Results announcement. Given the nature of the document as a reply slip for an EGM, it best fits under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2020-01-10 English
Form of Proxy for the First H Shares Class Meeting of 2020
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for the First H Shares Class Meeting of 2020 of Pharmaron Beijing Co., Ltd. It is a voting proxy form allowing shareholders to appoint a proxy to vote on their behalf at a specific shareholders' meeting. The content focuses on voting instructions for a special resolution related to an increase of registered capital. This type of document is not a report, financial statement, or announcement of results but a proxy solicitation document used to facilitate shareholder voting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is 5311 characters, consistent with a detailed proxy form. No financial data or report publication is included, and it is not an announcement of voting results but the solicitation for votes.
2020-01-10 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.